Minerva Neurosciences, Inc

NetDania - New 12 months High: Minerva Neurosciences, Inc

20 Sep 2018 09:57:47 By NetDania Notify

NetDania - New 12 months High: Minerva Neurosciences, Inc

18 Sep 2018 10:09:54 By NetDania Notify

NetDania - New 12 months High: Minerva Neurosciences, Inc

13 Sep 2018 11:26:55 By NetDania Notify

NetDania - New 12 months High: Minerva Neurosciences, Inc

31 Aug 2018 11:10:54 By NetDania Notify

NetDania - New 12 months High: Minerva Neurosciences, Inc

24 Aug 2018 11:02:01 By NetDania Notify

NetDania - New 12 months High: Minerva Neurosciences, Inc

23 Aug 2018 09:44:56 By NetDania Notify

NetDania - New 12 months High: Minerva Neurosciences, Inc

22 Aug 2018 13:34:16 By NetDania Notify

Minerva Neurosciences Announces Findings Showing Effect of Roluperidone on Brain-Derived Neurotrophic Factor (BDNF)

22 Aug 2018 10:11:04 By Nasdaq GlobeNewswire

Minerva Neurosciences Reports Second Quarter 2018 Financial Results and Business Updates

02 Aug 2018 07:30:44 By Nasdaq GlobeNewswire

Minerva Neurosciences to Report Second Quarter 2018 Financial Results and Business Updates on August 2, 2018

26 Jul 2018 08:30:31 By Nasdaq GlobeNewswire

Minerva Neurosciences Names Devin Smith Senior Vice President, General Counsel

25 Jul 2018 08:00:15 By Nasdaq GlobeNewswire

Minerva Neurosciences Elects Jeryl Hilleman to Board of Directors

17 Jul 2018 16:05:30 By Nasdaq GlobeNewswire

Minerva Neurosciences to Present at Jefferies 2018 Global Healthcare Conference on June 6, 2018

30 May 2018 08:30:41 By Nasdaq GlobeNewswire

Journal of Clinical Psychiatry Publishes Positive Results of Cognitive Performance From Phase 2B Trial of Roluperidone, Under Development by Minerva Neurosciences for the Treatment of Negative Symptoms in Schizophrenia

17 May 2018 08:01:03 By Nasdaq GlobeNewswire

Minerva Neurosciences Reports First Quarter 2018 Financial Results and Business Updates

03 May 2018 07:30:13 By Nasdaq GlobeNewswire

Minerva Neurosciences to Report First Quarter 2018 Financial Results and Business Updates on May 3, 2018

26 Apr 2018 08:30:48 By Nasdaq GlobeNewswire

Minerva Neurosciences Screens First Patient in Phase 2b Trial of MIN-117 to Treat Major Depressive Disorder

09 Apr 2018 08:30:41 By Nasdaq GlobeNewswire

Minerva Neurosciences to Host Key Opinion Leader Meeting on the Negative Symptoms of Schizophrenia on Thursday, March 22

15 Mar 2018 08:30:48 By Nasdaq GlobeNewswire

Minerva Neurosciences Reports Fiscal 2017 Fourth Quarter and Year End Financial Results and Business Updates

12 Mar 2018 07:30:21 By Nasdaq GlobeNewswire

Minerva Neurosciences to Report Fiscal 2017 Fourth Quarter and Year End Financial Results and Business Updates on March 12, 2018

05 Mar 2018 08:30:27 By Nasdaq GlobeNewswire